Cell-Based Vaccine Methane Reduction Ruminants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inhibiting methanogens in ruminants have been largely ineffective due to low efficacy, poor selectivity, toxicity, and resistance issues, particularly in extensive production environments where precise daily dosages are difficult to maintain.
Innovation Solution
Development of cell-based vaccines targeting cell surface antigens or fragments of methanogens, which induce an immune response and antibody production, reducing methane production in ruminants by impairing methanogen activity in the rumen.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If feed additives and antibiotics are used to inhibit methanogens, then methane production is reduced, but these solutions are only applicable to intensive production environments where precise daily dosages can be controlled
Solution Approach 1:
The vaccine is administered to ruminants in advance, allowing the immune system to develop antibodies against methanogens before methane production becomes a problem. This preliminary immune preparation eliminates the need for continuous daily dosing with feed additives or antibiotics, making the solution applicable to both intensive and extensive production environments where daily dosage control is difficult.
2Object-generated harmful factors
If methanogens are inhibited using conventional compounds, then methane emissions are reduced, but the compounds exhibit low efficacy, poor selectivity, toxicity, and resistance issues
Solution Approach 1:
The vaccine introduces an intermediary mechanism - the host's immune system - to combat methanogens. Instead of using direct chemical compounds that contact methanogens in the rumen, the vaccine triggers the production of antibodies that selectively target and neutralize methanogens. This immune-mediated approach provides high efficacy and selectivity without the toxicity and resistance problems associated with conventional anti-methanogen compounds.
3Reliability
If ruminants are vaccinated with cell-based vaccines targeting methanogen antigens, then immune response and antibody production are induced, but the challenge remains to produce antibodies that can effectively neutralize methanogens in the rumen
Solution Approach 1:
The vaccine extracts and presents specific cell surface antigens from methanogens to the ruminant's immune system. By isolating and presenting these key antigenic components, the vaccine directs the immune system to produce highly specific antibodies that recognize and bind to methanogen surface structures, enabling effective neutralization of methanogen activity in the rumen environment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The vaccines achieve a significant reduction in methane emissions by ruminants, with a 17% reduction in methane production sustained over five weeks, equivalent to 0.3-0.4 tonnes of mitigated methane per ruminant per year.
Implementation Method 1
vaccines of the present disclosure (e.g., cell-based vaccines comprising a cell and/or a cell part) against at least one cell surface antigen or a fragment thereof (e.g., antigenic fragment, epitope) of at least one methanogen, when administered to a subject (e.g., animal, ruminant), are surprisingly effective in inducing immune response and antibody production against the methanogen
Implementation Method 2
inducing immune response and antibody production against the methanogen, and reducing the CH4 production in ruminants
Implementation Method 3
At least a portion of the produced antibodies are present in the ruminant's saliva, which then pass to the ruminant's rumen and bind with the methanogens, e.g., those that convert H2 and CO2 into CH4. The antibody must then impair the methanogen thereby reducing total CH4 production in the rumen
Implementation Method 4
Ruminal methanogens principally use H2 to reduce CO2 to CH4 in a series of reactions that are coupled to ATP synthesis
Data Source
AI summary
The present invention relates to cell-based vaccine compositions and methods that reduce methane and/or hydrogen production in animals. The present invention relates to the treatment of diseases that are associated with methanogens. The present invention also relates to methods of growing hydrogenotrophs in safe anaerobic conditions.